Federal SB4327 mandates review of pharmaceutical products from Chinese entities to ensure they are not affiliated with the Chinese government, party.

Federal SB4327, known as the Securing America’s Drug Supply from Communist China Act, requires the Secretary of Health and Human Services to review drug applications to ensure sponsors are not affiliated with the Chinese government, party, or military. This includes reviewing applications submitted since January 1, 2016, and those submitted after the bill's enactment. The Secretary must refuse approval for applications from such entities and refuse import of drugs from these entities unless a waiver is granted to prevent drug shortages. The Commissioner of U.S.

Federal SB4327 mandates review of pharmaceutical products from Chinese entities to ensure they are not affiliated with the Chinese government, party.

Federal SB4327, known as the Securing America’s Drug Supply from Communist China Act, requires the Secretary of Health and Human Services to review drug applications to ensure sponsors are not affiliated with the Chinese government, party, or military. This includes reviewing applications submitted since January 1, 2016, and those submitted after the bill's enactment. The Secretary must refuse approval for applications from such entities and refuse import of drugs from these entities unless a waiver is granted to prevent drug shortages. The Commissioner of U.S.